Please check your internet connection and try again.
# Isoxsuprine Hydrochloride
## Overview
Isoxsuprine hydrochloride is a vasodilator that primarily acts on blood vessels to increase blood flow. Its exact mechanism of action is not fully understood but is thought to involve direct relaxation of vascular smooth muscle.
## Primary Indications
* Peripheral vascular disease, including intermittent claudication and arteriosclerosis obliterans, to improve blood flow to the extremities.
## Adult Dosing
* Oral: The typical dose is 10-20 mg every 4-6 hours.
* Maximum dose: Not well-established, but doses exceeding 20 mg per administration may increase adverse effects. Dosing should be individualized based on patient response.
## Pediatric Dosing
* There is no established pediatric dosing for isoxsuprine hydrochloride. Its use in children is not recommended due to lack of data.
## Dose Adjustments
* Renal Impairment: No specific dose adjustments are established. Use with caution, as renal impairment can affect drug clearance.
* Hepatic Impairment: No specific dose adjustments are established. Use with caution.
## Contraindications
* Hypersensitivity to isoxsuprine hydrochloride.
* Should not be administered intravenously due to potential for severe adverse effects, including hypotension and tachycardia.
## Adverse Effects
* Common: Nausea, vomiting, stomach upset, dizziness, weakness, flushing, rash.
* Less Common: Hypotension, tachycardia, blurred vision, drowsiness, nervousness.
## Key Drug Interactions
* Antihypertensives: Isoxsuprine may potentiate the hypotensive effects of antihypertensive medications.
* Other vasodilators: Concurrent use may lead to additive hypotensive effects.
## Monitoring
* Blood pressure and heart rate.
* Signs and symptoms of peripheral vascular disease (e.g., improvement in claudication, skin temperature, color).
* Adverse effects.
## Clinical Pearls
* Efficacy in peripheral vascular disease is controversial and often considered limited.
* Oral administration is the only recommended route.
* Patients with cardiac conditions, such as recent myocardial infarction or arrhythmias, should be monitored closely.
***
**Disclaimer:** This information is intended for healthcare professionals and does not substitute for clinical judgment. Always consult the most current prescribing information and relevant literature for comprehensive and up-to-date guidance.
